ChemAxon, a leader in chemistry software solutions and consulting services for life science research, has announced version 6 of its cheminformatics suite
ChemAxon, a provider of chemistry software solutions and consulting services for life science research, has announced that the crowd-sourced chemical structures gathered via its public website have been deposited to the PubChem repository
JChem cartridge achieves Oracle Exadata-ready status
ChemAxon has announced that its free, open access, web-based chemistry search and extraction service, chemicalize.org, is now supported on touchscreen tablet PCs, including Apple iPads and Android devices
ChemAxon has launched JChem for Excel, an add-in for Microsoft Excel that brings all of the capabilities and performance of the JChem and Marvin platform to Excel users
ChemAxon has launched v5.2 of its cheminformatics toolkits Marvin and JChem, with many new functionalities added, new integration options and improvements in search performance
ChemAxon has launched version 5.1 of its cheminformatics toolkits, Marvin and JChem. As well as other improvements, the release sees the introduction of IUPAC name import, support for OLE 2 format useful for integrating with Microsoft Office applications.
ChemAxon has released version 5 of its cheminformatics toolkits, Marvin & JChem. The release sees major improvements in Marvin user friendliness, Markush enumeration and core development in JChem search, clustering and Oracle Cartridge performance.
ChemAxon has released Instant JChem Version 2, a desktop application for working with chemical data on local and remote databases. The new release allows relational data support and advanced query building.
The automotive sector is undergoing a period of rapid and disruptive transformation from both a business and technical standpoint.
Estimates suggest that the global laboratory informatics market, valued at $2.6 billion in 2019, will witness CAGR of 7.5 per cent over the next five years, reaching $3.8 billion in 2024[1].
Modern drug discovery and development workflows incorporate a growing range of automated, high-throughput technologies that can generate data on a truly impressive scale.
‘This will be the life sciences century … because of personalised medicine, information technology, and knowledge on biological systems,’ said Fred Hassan, a partner of Warburg Pincus and former CEO of Schering-Plough.
With data rates increasing and more complex challenges arising in life sciences, Panasas’ Jim Donovan and Dale Brantly discuss the benefits of using HPC for these workloads
As the complexity of both HPC hardware and the challenges that scientists are trying to solve using HPC systems increases, ensuring a system is utilised efficiently is necessary to deliver a computing service with value for money and a high research output.
Architectural specialisation is one option to continue to improve performance beyond the limits imposed by the slow down in Moore’s Law.
As not only the HPC industry but the larger computing ecosystem tries to overcome the slowdown and eventual end of transistor scaling described by Moore’s Law, scientists and researchers are implementing programmes that will define the technologies and new materials needed to supplement, or repla
